2020 International Conference on Vaccines Research and Development (Vaccines R&D 2020) October 19-20, 2020 Cairo, Egypt is a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas & establish business and research collaborations.
With the participants from around the globe focused on learning about vaccines research & development and its advances, this is your best opportunity to reach the largest assemblage of experts from the vaccines community. Presentations, exchanging recent research information, connect with potential scientists, make a splash with new and recent vaccines developments, and receive name recognition at this event. Eminent speakers, advanced techniques, developments, and the newest updates in vaccines research & development are hallmarks of this conference.
We wish to see you at Vaccines R&D 2020 Cairo, Egypt
In 2018, the FDA approved a new hexavalent vaccine, DTaP5-HB-IPV- Hib (Vaxelis, Merck) for primary and booster vaccinati
Some of the vaccines may be given as part of a combination vaccine so that a child gets fewer shots
Process that uses complete living cells or their components to obtain desired products.
Traditional vaccines against those viruses, such as the HPV vaccine and the hepatitis B vaccine, prevent those types of
Prospective biomedical or behavioral research studies on human participants are designed to answer specific questions
HIV infections, SARS, Lyme disease, Escherichia coli...
Protecting individuals who do not have HIV from being infected with the virus
ID are disorders caused by organisms such as bacteria, viruses, fungi or parasites. NID either contagious nor communicab
How to protect yourself when travelling
(World HealthOrganization (WHO) Video)